These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 19652037)

  • 1. The new data on prostate cancer screening: what should we do now?
    Gilligan T
    Cleve Clin J Med; 2009 Aug; 76(8):446-8. PubMed ID: 19652037
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 3. What's new in prostate cancer screening and prevention?
    Klein EA
    Cleve Clin J Med; 2009 Aug; 76(8):439-45. PubMed ID: 19652036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer screening "reloaded".
    Gomella LG
    Can J Urol; 2010 Apr; 17(2):5057. PubMed ID: 20398441
    [No Abstract]   [Full Text] [Related]  

  • 5. [Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis].
    Borkowetz A
    Urologe A; 2019 Aug; 58(8):925-928. PubMed ID: 31240375
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer screening.
    Catalona WJ
    BJU Int; 2004 Nov; 94(7):964-6. PubMed ID: 15541107
    [No Abstract]   [Full Text] [Related]  

  • 7. In this issue: mini-theme on geriatric care and cancer screening.
    Bowman MA; Neale AV
    J Am Board Fam Med; 2009; 22(3):231-3. PubMed ID: 19429726
    [No Abstract]   [Full Text] [Related]  

  • 8. Early detection of prostate cancer.
    Taneja SS
    Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate Cancer Screening and the Associated Controversy.
    Tabayoyong W; Abouassaly R
    Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening for men aged 75 to 84 years in New South Wales.
    Carmichael LK; Goldsbury DE; O'Connell DL
    Aust N Z J Public Health; 2013 Oct; 37(5):492-4. PubMed ID: 24090337
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
    Carroll PR; Whitson JM; Cooperberg MR
    J Clin Oncol; 2011 Feb; 29(4):345-7. PubMed ID: 21189396
    [No Abstract]   [Full Text] [Related]  

  • 12. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for prostate cancer remains controversial.
    Neal DE; Donovan JL; Martin RM; Hamdy FC
    Lancet; 2009 Oct; 374(9700):1482-3. PubMed ID: 19664817
    [No Abstract]   [Full Text] [Related]  

  • 14. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761
    [No Abstract]   [Full Text] [Related]  

  • 15. From the Centers for Disease Control and Prevention. Screening with the prostate-specific antigen test--Texas, 1997.
    JAMA; 2000 Nov; 284(18):2313-4. PubMed ID: 11184781
    [No Abstract]   [Full Text] [Related]  

  • 16. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer screening: what we know, don't know, and believe.
    Brawley OW
    Ann Intern Med; 2012 Jul; 157(2):135-6. PubMed ID: 22801675
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer: Numeracy and understanding of risk reduction of PSA screening.
    Subramanian V; Kattan MW
    Nat Rev Urol; 2018 Apr; 15(4):208-209. PubMed ID: 29460924
    [No Abstract]   [Full Text] [Related]  

  • 19. Is screening for prostate cancer the current gold standard?--"yes".
    Lange PH
    Eur J Cancer; 1997 Mar; 33(3):354-6. PubMed ID: 9155516
    [No Abstract]   [Full Text] [Related]  

  • 20. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
    Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
    JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.